当前位置: 首页 > 医疗版 > 疾病专题 > 妇产科 > 女性生殖器官肿瘤及肿瘤样病变 > 子宫肌瘤
编号:13634516
缩宫素在黏膜下子宫肌瘤切术中应用的效果评价(1)
http://www.100md.com 2015年8月25日 《中外医疗》 201524
     [摘要] 目的 探讨缩宫素预处理对宫腔镜电切黏膜下子宫肌瘤临床效果的作用。方法 随机选取该院于2012年2月—2014年2月期间收治的100例黏膜下子宫肌瘤患者随机分为研究组(52例)和对照组(48例),研究组术前3 d连续肌注缩宫素后行宫腔镜电切,对照组直接行宫腔镜电切,比较两组患者手术时间、术中出血量、液体吸收量等,并随访研究患者治疗疗效及妊娠情况。结果 研究组患者手术时间短于对照组、术中出血量及液体吸收量少于对照组的,术后肛门排气时间(9.0±3.4)h短于对照组,住院时间短于对照组,差异有统计学意义(P<0.05)。术后随访6个月,两组患者月经量改变及不规则阴道流血无明显改善(P>0.05),研究组患者残留肌瘤复发率明显低于对照组(P<0.05)。结论 缩宫素预处理后行宫腔镜电切处理黏膜下子宫肌瘤,减少手术时间,减少术中出血量及液体吸收量,降低残留肌瘤复发率,值得临床进一步研究推广。

    [关键词] 黏膜下子宫肌瘤;缩宫素;宫腔镜

    [中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2015)08(c)-0142-03

    Oxytocin in the Submucous Uterine Myoma Resection Application Effect Evaluation

    YANG Hua-ping

    Department of Gynaecology, Tech Industrial Development Zone People's Hospital of Linyi City, Linyi, Shandong Province, 276002 China

    [Abstract] Objective To study the oxytocin pretreatment of hysteroscopic submucosal uterine fibroids clinical effect. Methods 100 patients with submucosal uterine fibroids from 2012 Februay to 2014 February were randomly divided into research group (52 cases) and control group (48 cases),two groups at random number should be much fewer, the team before 3 days consecutive intramuscular injection of oxytocin after hysteroscopic, control line of hysteroscopic directly, compare two groups of patients with operation time, intraoperative blood loss, such as liquid absorption, and follow-up study the curative effect and patients with pregnancy. Results The patients with team operation time is shorter than the control group, intraoperative blood loss and liquid absorption is less than the control group, postoperative anal exhaust time (9.0±3.4),unit of measurement data is shorter than the control group, hospital was shorter than the control group, the difference had statistical significance (P< 0.05). Postoperative follow-up of 6 months, two groups of patients with no obvious improve menstrual quantity change and irregular vaginal bleeding (P > 0.05), the team residual myoma recurrence in patients with significantly lower than the control group (P < 0.05). Conclusion Oxytocin pretreatment by hysteroscopic treatment of the submucous uterine fibroids, reduce the operation time, less intraoperative blood loss, and liquid absorption, reduce the residual myoma recurrence rate, worthy of further clinical research.

    [Key words] Submucosal Uterine Fibroids; Oxytocin; Hysteroscopy

    子宫肌瘤是育龄期妇女的常见病,好发于30~50岁的妇女,发病率达20%~70%,一般认为约1/3的妇女患有子宫肌瘤[1]。黏膜下子宫肌瘤是子宫肌瘤常见的类型,患者特征性临床表现为月经量过多、经期时间延长。随着微创技术的发展,宫腔镜在妇科疾病中应用逐渐广泛。宫腔镜切除黏膜下子宫肌瘤,在保留子宫的同时还不损害卵巢功能,对患者生育能力无影响,但是黏膜下子宫肌瘤的类别、大小、血运、位置等因素与手术操作有直接联系。宫腔镜电切黏膜下子宫肌瘤的手术操作较为复杂,手术时间越长患者术后并发症的发生率越高。经尿道前列腺电切(TURP)综合征、子宫穿孔、出血是宫腔镜手术的主要并发症[2]。该研究随机选取2012年2月—2014年2月期间该院收治的100例患者为研究对象,以探讨缩宫素预处理对宫腔镜电切子宫肌瘤的效果,现报道如下。, 百拇医药(杨华平)
1 2 3下一页


    参见:首页 > 医疗版 > 疾病专题 > 妇产科 > 女性生殖器官肿瘤及肿瘤样病变 > 子宫肌瘤